(Total Views: 301)
Posted On: 10/19/2022 4:50:52 PM
Post# of 63
$MTNB News Article - Matinas BioPharma Announces Infectious Diseases Society of America (IDSA) has Selected the EnACT Phase 2 Trial Abstract of MAT2203 as its Outstanding Abstract and IDSA Awardee For IDWeek 2022 https://marketwirenews.com/news-releases/mati...57280.html
(1)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
